PLA2G16 Antikörper (AA 2-15)
-
- Target Alle PLA2G16 Antikörper anzeigen
- PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
-
Bindungsspezifität
- AA 2-15
- Reaktivität
- Human, Affe, Kaninchen
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PLA2G16 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Marke
- IHC-plus™
- Spezifität
- Human PLA2G16. Reported variants represent identical protein:NP_009000.2 and NP_001121675.1).
- Homologie
- Percent identity by BLAST analysis: Human, Gorilla, Orangutan, Gibbon, Marmoset, Rabbit (100%) Mouse (93%) Monkey, Rat, Bovine (86%).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide RAPIPEPKPGDLIE-C from the N-terminus of human PLA2G16 (NP_009000.2). Percent identity by BLAST analysis: Human, Gorilla, Orangutan, Gibbon, Marmoset, Rabbit (100%), Mouse (93%), Monkey, Rat, Bovine (86%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product PLA2G16 Primärantikörper
-
-
- Applikationshinweise
-
Approved: IHC, IHC-P (5 μg/mL), Peptide-ELISA (1:128000)
Usage: Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for this antibody was determined to be 5 μg/mL. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Tris-buffered saline, pH 7.3, 0.5 % BSA, 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze-thaw cycles.
-
- Target
- PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
- Andere Bezeichnung
- PLA2G16 / HRASLS3 (PLA2G16 Produkte)
- Synonyme
- HRASLS3 antikoerper, HREV107 antikoerper, HRSL3 antikoerper, AdPLA antikoerper, H-REV107-1 antikoerper, HREV107-1 antikoerper, HREV107-3 antikoerper, C78643 antikoerper, Hrasls3 antikoerper, Hrev107 antikoerper, MLP-3 antikoerper, phospholipase A2 group XVI antikoerper, phospholipase A2, group XVI antikoerper, PLA2G16 antikoerper, Pla2g16 antikoerper
- Hintergrund
-
Name/Gene ID: PLA2G16
Synonyms: PLA2G16, AdPLA, Adipose-specific PLA2, Group XVI phospholipase A1/A2, Group XVI phospholipase A2, H-REV107-1, HRAS-like suppressor 3, HRASLS3, HREV107-3, HRAS-like suppressor 1, HREV107-1, H-rev 107 protein homolog, HREV107, HRSL3, Phospholipase A2, group XVI - Gen-ID
- 11145
- NCBI Accession
- NP_009000
- UniProt
- P53816
- Pathways
- Inositol Metabolic Process
-